banner
You are here:HomeFor CliniciansWhat CMS says about PT/INR self-testing
For Patients
What is PT/INR Self Testing?
How Self Testing Works
Benefits of Self Testing
Is Self Testing for You?
INR Meters
What People Say
Medications & Diet
Frequently Asked Questions
Get Started Now
For Clinicians
Improving Outcomes
How Self Testing Works
Which Patients Qualify
What Doctors Say
About the Meters
Frequently Asked Questions
Prescription - Rx
Clinician Info Kit
Published Research
Practical Implementation

About Us

What CMS says about PT/INR self-testing

In a 2001 Decision Memoradum, Medicare cites clinical evidence supporting Coumadin self-testing on a weekly basis. The Centers for Medicare and Medicaid (CMS) concluded:

  •  The studies reviewed demonstrated home PT/INR monitoring significantly improves time in therapeutic range for select groups of patients, compared to testing done in physician offices or anticoagulation clinics.

  • Increased time in therapeutic range leads to improved clinical outcomes, with reductions in thromboembolic and hemorrhagic events.

  • In order to achieve time in therapeutic range of 90%, a patient most likely needs to be tested once a week.

(CMS Decision Memorandum #CAG-00087N September 18, 2001)

 

Click here to read and/or download a copy of the CPT codes and additional information from CMS.